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The cellular localization of the Epstein-Barr virus-encoded RK-BARF0 protein was analyzed by fluorescence
microscopy and immunoblotting. The recombinant RK-BARF0 protein was found to be tightly bound to
nuclear structures, whereas 16- to 20-kDa RK-BARF0 derivatives, generated by differential splicing of the
RK-BARF0 transcript, were present throughout the cell. Moreover, a previously generated anti-RK-BARF0
rabbit serum was found to cross-react with cellular proteins, showing that the previously identified 30- to
35-kDa membrane-associated proteins do not represent RK-BARF0.
Epstein-Barr virus (EBV) is associated with three lympho-
proliferative diseases of B-cell origin: acute infectious mono-
nucleosis, endemic Burkitt’s lymphoma (BL), and lymphoma
occurring in immunocompromised individuals. In addition, it
has been shown that there is a likely etiologic role for EBV in
the development of undifferentiated nasopharyngeal carci-
noma (NPC) (14). Studies have shown the presence of right-
ward transcripts from the BamHI A region of EBV in NPC
tumor tissue. Sequence analyses of cDNA clones from a tran-
scription library of a tumor xenograft (C15) suggested that
primary transcripts were subjected to differential splicing, giv-
ing rise to the existence of a family of related transcripts in
NPC tissues (4, 5, 7, 9, 18). All NPC tissues tested contained
either four or five rightward transcripts of BamHI A which
have a common 39 terminal open reading frame (ORF),
termed BARF0. PCR analyses and in situ hybridization, using
a riboprobe specific for the BARF0 ORF, also detected
BamHI A transcripts in EBV-positive BL cell lines as well as in
all EBV-transformed lymphoblastoid cell lines (LCLs) studied
(4).
In a recent study (15), cDNA cloning, reverse transcriptase-
PCR (RT-PCR), and Northern blotting were used to further
define the structures of the BamHI A rightward transcripts.
Three BamHI A cDNAs were isolated and found to be previ-
ously unidentified mRNAs that contained the BARF0 ORF
and additional ORFs encoded by multiple exons, including
one, termed RK-BARF0, which extended the size of the
BARF0 ORF from 174 to 279 amino acids (aa). Fries et al. (6)
raised a rabbit antiserum to a synthetic peptide containing an
amino acid sequence encoded within the BARF0 ORF. This
antiserum detected a glutathione S-transferase–BARF0 fusion
protein and both BARF0 and RK-BARF0 proteins expressed
from transfected constructs in H1299 epithelial cells. The se-
rum also immunoprecipitated the 20-kDa protein BARF0 and
the 30-kDa protein RK-BARF0 translated in vitro and identi-
fied a membrane-associated doublet of 30- and 35-kDa pro-
teins in all of the EBV-infected cell lines tested.
In further work the BARF0 ORF was shown to encode an
HLA class I-restricted cytotoxic T lymphocyte (CTL) epitope
which was recognized by CTLs from EBV-seropositive, but not
-seronegative, individuals (11). In EBV-positive cells this CTL
epitope was found to be effectively removed by differential
splicing of the BARF0 ORF. These splicing events also re-
sulted in the generation of novel RK-BARF0 protein deriva-
tives of 16 to 20 kDa (10).
Cellular localization of RK-BARF0. In order to further char-
acterize the biological functions of RK-BARF0 and BARF0
the cellular localization of these proteins was analyzed. The
Flag-RK-BARF0 and BARF0 cDNAs (6) were cloned into the
KpnI-BamHI and BamHI sites, respectively, of the vector
pEGFP-C1 (Clontech) and were transiently expressed in the
EBV-negative BL cell line DG75 (3). Localization of the green
fluorescent protein (GFP) fusion proteins (GFP-Flag-RK-
BARF0 and GFP-BARF0) and GFP alone was determined by
fluorescence microscopy on living cells (Fig. 1A). As expected,
GFP alone, being present in both the nucleus and cytoplasm,
was distributed throughout the cell. In contrast, both the GFP-
Flag-RK-BARF0 and GFP-BARF0 cell transfectants showed
prominent nuclear staining that formed bright condensed
structures. This result was surprising, as RK-BARF0 was
thought to be membrane associated (6). As the cytoplasm of
DG75 cells is fairly small it was difficult to determine the
proportions of GFP-Flag-RK-BARF0 and GFP-BARF0 that
were present in the cytoplasm. To confirm that RK-BARF0
was indeed associated with the nucleus, Flag-tagged RK-
BARF0 cDNA, cloned into the expression vector EBO-pLPP
(10), was transiently introduced into HeLa cells or stably ex-
pressed in DG75 cells. The transfected cell lines were treated
with propidium iodide (2 mg per ml) to stain nucleic acid and
with anti-Flag monoclonal antibody (MAb) (diluted 1:60 in
phosphate-buffered saline) (Eastman Kodak) to identify Flag-
tagged proteins. Indirect immunofluorescence showed that the
Flag-tagged proteins were present throughout the cell but were
predominantly localized in the parts of the nucleus other than
the nucleoli (Fig. 1B). These results confirmed the data for
localization of the GFP fusion proteins and indicated that a
sequence within the BARF0 ORF was sufficient for targeting
the proteins to the nucleus.
Fractionation of cells expressing Flag-RK-BARF0 and its
derivatives. We have previously shown that the RK-BARF0
transcript undergoes differential splicing utilizing an identical
59 splice site and one of three different 39 splice sites. This
results in the generation of three RK-BARF0 derivatives of
190 or 177 aa and a frameshifted chimeric protein product
(which is totally unrelated to RK-BARF0 in its C-terminal
half) of 150 aa (10) (Fig. 2A). To confirm the fluorescence
study results and to determine whether the RK-BARF0 16- to
20-kDa protein derivatives were also localized to the nucleus,
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DG75 cells stably expressing Flag-RK-BARF0 were fraction-
ated into nuclear, membrane, and cytoplasmic fractions as
described recently (6). Protein was detected by immunoblot-
ting by using an anti-Flag antibody, diluted 1:300 (12). The
total lysate of transfected cells showed low amounts of full-
length RK-BARF0 protein but high levels of 16- to 20-kDa
Flag-tagged RK-BARF0 derivative proteins (Fig. 2B). The 32-
kDa Flag-RK-BARF0 protein was found to be almost exclu-
sively associated with the nuclear fraction, while the 16- to
20-kDa derivatives were present in all cellular fractions. These
results indicated that the sequence responsible for the nuclear
association of RK-BARF0 was encoded within the region
which was removed by splicing of the RK-BARF0 transcript.
Interestingly, the region removed was arginine rich and had
been suggested to be involved in binding of nucleic acids (15).
To determine whether full-length RK-BARF0 was free in
the nucleoplasm or was associated with structures within the
nucleus, nuclei were prepared from DG75 cells stably express-
ing Flag-RK-BARF0 and were extracted with buffers contain-
ing different concentrations of NaCl according to the method
of Sambrook et al. (16). Flag-RK-BARF0 was detected by
immunoblotting by using the anti-Flag MAb and was not re-
moved from the nucleus by washing with 150 mM NaCl, and
the majority of the protein remained associated with the nu-
clear pellet even after washing with 500 mM NaCl (Fig. 2C).
Taken together these data clearly demonstrated that the RK-
BARF0 protein was not membrane associated, as previously
FIG. 1. Fluorescence microscopy in transfected EBV-negative cells. The
tagged RK-BARF0 and BARF0 gene constructs are illustrated and include the
RK exon (open box), the BARF0 ORF (grey box), and the in-frame sequence
(dark grey box) located 59 of the BARF0 ORF (according to references 6 and 15)
as well as the Flag epitope (Flag) and GFP (cross-hatched box). The location of
the 20-mer peptide used to raise the polyclonal anti-RK-BARF0 rabbit serum (6)
is shown by a black oval. (A) DG75 cells were transiently transfected with
plasmids encoding GFP, GFP-Flag-RK-BARF0, or GFP-BARF0, and GFP flu-
orescence was analyzed in living cells. (B) The Flag-RK-BARF0 gene was either
transiently expressed in HeLa cells or stably expressed in DG75 cells. Cells were
stained with an anti-Flag MAb (anti-Flag) and propidium iodide (PI stain) and
analyzed by indirect immunofluorescence of fixed cells.
FIG. 2. Fractionation of EBV-negative DG75 cells expressing Flag-RK-
BARF0. (A) Summary of the differential splicing of RK-BARF0 as reported
recently (10). The locations of the splice sites are shown, and the sizes (in amino
acids) of the full-length Flag-tagged RK-BARF0 and its 16- to 20-kDa protein
derivatives are given. For graphic details see the legend of Fig. 1. Note that the
products F-S#1 and F-S#2 maintain the BARF0 frame, whereas F-S#3 under-
goes a frameshift in its C terminus (cross-hatched). (B) Cells stably expressing
Flag-RK-BARF0 were separated into nuclear (N), membrane (M), and cyto-
plasmic (C) fractions. For controls, total extracts of cells expressing either the
control vector (lane 1) or Flag-RK-BARF0 (lane 2) were used. Total and frac-
tionated proteins were separated by SDS–12% polyacrylamide gel electrophore-
sis, and their expression was analyzed by immunoblotting by using an anti-Flag
MAb. Molecular size markers (expressed in kilodaltons) are shown, and the
positions of Flag-RK-BARF0 and its 16- to 20-kDa derivatives are indicated by
arrows. (C) Cells stably expressing Flag-RK-BARF0 were separated into cyto-
plasmic (C) and nuclear fractions. Samples of the nuclear extract were then
incubated with buffers containing either low (150 mM) or high (500 mM) NaCl
concentration, and the corresponding nuclear supernatant (w) and pellet (p)
were collected and analyzed by immunoblotting.
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thought (6), but was instead localized to structures within the
nucleus.
Specificity of the polyclonal rabbit RK-BARF0 antiserum.
The study generating the original data on the membrane lo-
calization of RK-BARF0 utilized cellular fractionation of an
EBV-positive LCL and a polyclonal rabbit anti-RK-BARF0
serum (6). This anti-RK-BARF0 serum (diluted 1:1,000) was
therefore utilized to probe the Flag-RK-BARF0-expressing
DG75 cell fractions. As shown in Fig. 3A, the 30- and 35-kDa
proteins, previously identified by Fries et al. (6), were as ex-
pected present primarily in the membrane fraction, suggesting
that they did not represent RK-BARF0. More importantly,
these proteins were also detected in the EBV-negative DG75
cells (Fig. 3C, lane 1), indicating that the anti-RK-BARF0
serum cross-reacted with cellular proteins.
To confirm that the 30- and 35-kDa proteins detected with
the rabbit antiserum were of cellular origin, a panel of EBV-
negative B-cell lines was examined by immunoblotting by using
this antiserum (Fig. 3B). The results were in agreement with
the data presented by Fries et al. (6) in that neither BJAB nor
Ramos cell lines (1) expressed the 30- and 35-kDa proteins.
However, the 30- and 35-kDa proteins were identified in the
EBV-negative BL cell lines BL41, BL30K, DG75, and BL30A
(13) and in an EBV-positive control LCL. The BL41, BL30,
and DG75 cell lines were confirmed to be EBV negative by
DNA PCR, RT-PCR, and immunoblotting (data not shown).
To ensure that the sample of rabbit serum being used still
retained its reactivity to the epitope within the BARF0 ORF,
against which it was raised, immunoblot analyses of DG75 cells
expressing either GFP-Flag-RK-BARF0, GFP-BARF0, or Flag-
RK-BARF0 were performed. By using the rabbit antiserum,
GFP-Flag-RK-BARF0 and GFP-BARF0 were detected on the
immunoblots, demonstrating that the rabbit serum indeed con-
tained antibodies specific for BARF0 (Fig. 3C, lanes 2 and 3).
Detection of Flag-RK-BARF0 was difficult not only because
this protein has the same molecular weight as the 35-kDa
cellular cross-reactive protein but also because the differential
splicing of the RK-BARF0 message largely reduced the
amount of full-length protein (lanes 1 and 4). By using the
anti-Flag MAb both the GFP-Flag-RK-BARF0 and the Flag-
RK-BARF0 proteins were detected. The anti-Flag MAb also
reacted with smaller Flag-tagged protein products, of approx-
imately 60 kDa and 16 to 20 kDa in size, which originated from
differential splicing of the GFP-RK-BARF0 and RK-BARF0
messages, respectively (Fig. 3C, lanes 3 and 4). Consequently,
these proteins were not detected by the rabbit anti-RK-BARF0
serum, as the differential splicing caused the loss of the B-cell
epitope region used to raise the rabbit antiserum. These data
demonstrated that the membrane-associated 30- and 35-kDa
proteins, detected by the rabbit anti-RK-BARF0 serum, did
not represent RK-BARF0 and were cellular in origin. The
presence of these cellular proteins would have masked any
virus-encoded RK-BARF0 protein expressed in the EBV-pos-
itive cell lines.
Analyses of BARF0 transcripts in EBV-infected cells. In
EBV-positive BL cells, LCLs, and NPC cells, transcripts en-
coding the BARF0 ORF were recently shown to utilize a 59
splice site and one of three different 39 splice sites (10). The
expression pattern of the BamHI A rightward messages is very
complex, and so far no major transcript has been described. To
obtain a semiqualitative estimation of the frequency of the
differentially spliced BARF0 transcripts, expressed relative to
the amounts of all of the BamHI A transcripts, RT-PCR was
performed as outlined recently (10). Briefly, total RNA from a
panel of EBV-positive cells was reverse transcribed with
oligo-dT primers. For negative controls, water and the RT
sample missing the RT enzyme were used. A positive control
consisted of plasmid DNA of Flag-RK-BARF0. The primers
BARF0-F3 (59-TCTGCCGTGAAGGGTTG; position 160789
within the B95.8 EBV genome [2]) and BARF0-R6 (59-GTG
TTTTATTGCATGTCTCACACC; position 160973 within the
same genome) were specific for the 185-bp-long 39 end of the
BARF0 ORF and should represent all BamHI A transcripts.
The primers BARF0-F (59-GCCCGAGGAGCTGTAGACC;
position 160308 within the B95.8 EBV genome) and BARF0-R6
covered the complete BARF0 ORF and amplified full-length
(666 bp) and spliced forms (314, 353, and 363 bp) (Fig. 4A).
Comparison of the PCR-amplified products revealed that the
differentially spliced BARF0 products (Fig. 4B) composed a
FIG. 3. Specificity of the RK-BARF0 antiserum. (A) DG75 cells stably ex-
pressing Flag-RK-BARF0 were separated into nuclear (N), membrane (M), and
cytoplasmic (C) fractions and subjected to SDS–12% polyacrylamide gel elec-
trophoresis. For controls, total extracts of cells expressing either the control
vector (lane 1) or Flag-RK-BARF0 (lane 2) were used. (B) Total cell extracts of
the EBV-negative B-cell lymphoma line BJAB (lane 1), of the EBV-positive
LCL IS (lane 2), and of the EBV-negative BL cell lines BL41 (lane 3), BL30K
(lane 4), Ramos (lane 5), DG75 (lane 6), and BL30A (lane 7) were separated by
SDS–12% polyacrylamide gel electrophoresis. (C) Total cell extracts of DG75
cells transfected with plasmids encoding GFP (lane 1), GFP-BARF0 (lane 2),
GFP-Flag-RK-BARF0 (lane 3), and Flag-RK-BARF0 (lane 4) were separated by
SDS–10% polyacrylamide gel electrophoresis. Protein expression was analyzed
by immunoblotting by using either the polyclonal anti-RK-BARF0 serum or an
anti-Flag MAb (indicated at the bottom). Molecular size markers (expressed in
kilodaltons) are shown, and the positions of the cross-reactive 30- to 35-kDa
proteins and the tagged RK-BARF0 and BARF0 proteins are indicated at the
left. The asterisks mark proteins which were detected by the anti-Flag MAb but
not by the anti-RK-BARF0 serum.
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small but significant proportion of the total viral BamHI A
transcripts which were unspliced in their 39-terminal ends (Fig.
4C).
Analysis of RK-BARF0 expression in EBV-infected cells. To
further characterize the recombinant 16- to 20-kDa RK-
BARF0 protein derivatives, two-dimensional (2D) gel electro-
phoresis was employed. Protein extracts of the EBV-positive
cells of the NK LCL, which stably expressed either a control
vector or Flag-RK-BARF0 (10), were subjected to 2D gel
electrophoresis by using the Immobline Drystrip (pH range, 3
to 10.5) and an ExelGel sodium dodecyl sulfate (SDS) gradient
(8 to 18%) according to the instructions of the manufacturer
(Pharmacia), followed by immunoblotting by using an anti-
Flag MAb. The anti-Flag MAb detected three sets of proteins,
ranging from 16 to 20 kDa and with isoelectric point (pI)
values ranging between 5 and 8, in the Flag-RK-BARF0-trans-
fected cells but not in the control cells (Fig. 5A and B). These
values correlated well with the predicted sizes (Fig. 2A) and pI
values of the splice variants generated from the Flag-RK-
BARF0 message. Each set of Flag-tagged proteins consisted of
proteins with similar molecular weights but different pI values,
suggesting that these proteins were posttranslationally modi-
fied. Since the pattern of differential splicing within the
BARF0 mRNA also occurs in EBV-infected cells, as deter-
mined by RT-PCR, it is tempting to speculate that these trun-
cated protein variants may be expressed in vivo and have some
biological activity. Indeed, differential splicing is well known to
regulate gene expression and to create protein isoforms with
different functions (reviewed in reference 17).
In order to analyze RK-BARF0 expression in vivo, the mem-
branes were reprobed with the anti-RK-BARF0 serum, and
the analysis revealed two sets of protein spots with pI values of
approximately 5 to 7 and molecular masses of 30 to 35 kDa
(Fig. 5C and D). As these proteins were present in both control
transfectants and cell transfectants expressing Flag-RK-
BARF0, they probably corresponded to the 30- to 35-kDa
cross-reactive cellular proteins. Full-length RK-BARF0 was
not detected in any of the transfected LCLs, and this was
probably due to the small amounts of unspliced message ex-
pressed in the LCLs (Fig. 4, and see reference 10) and the high
theoretically predicted pI values (10.2 and 10.9, respectively)
(which were at the edge of the resolution of the 2D gel) for the
Flag-tagged RK-BARF0 and viral RK-BARF0.
In summary, this study, in contrast to a recent report (6),
demonstrates that the 30- to 35-kDa membrane-associated
proteins are not encoded by the viral RK-BARF0 transcripts
but instead are cellular proteins. This was clearly shown by
immunoblot analyses identifying the 30- to 35-kDa membrane-
associated proteins in a panel of EBV-negative BL cell lines. In
addition 2D gel electrophoresis revealed that the apparent pIs
of the 30- to 35-kDa membrane-associated proteins did not
match the theoretical pI of the RK-BARF0 sequence. Support
also came from fluorescence and fractionation assays using
Flag-tagged RK-BARF0 protein, which revealed that, rather
FIG. 4. RT-PCR of EBV-positive cells. (A) Schematic diagram of the
genomic RK-BARF0 organization in EBV and the locations of the primers used.
The numbering refers to the EBV sequence of strain B95.8 (2) and indicates
start, stop, and splice sites as reported recently (10, 15). For graphical details see
the legend of Fig. 1. (B) Total RNAs from the EBV-positive cell lines SB (an
LCL) (lane 1), MutuI-BL (lane 2), and MutuIII-BL (lane 3), from the tumor
xenograft C15-NPC (lane 4), and from EBV-negative DG75 cells stably express-
ing Flag-RK-BARF0 (lane 5) were analyzed by RT-PCR. The positive (1) and
negative (2) RT samples, the water control (W), and the positive control DNA
of the plasmid encoding Flag-RK-BARF0 (DNA) were amplified by using the
primers BARF0-F and BARF0-R6. The PCR products were separated and
visualized by electrophoresis on an ethidium bromide-containing 2.5% agarose
gel. Some markers of the 1-kbp DNA ladder (M) are shown on the right, and the
positions of the unspliced and spliced cDNAs are indicated by arrowheads. (C)
RT-PCR performed by using the primers BARF0-F3 and BARF0-R6. Lanes 1
through 5 correspond to the positive RT samples used in the RT-PCR shown in
panel B, and one negative RT sample is shown as a control. The molecular size
of the unspliced cDNA is given.
FIG. 5. 2D gel electrophoresis. Total cell extracts of NK LCLs stably express-
ing a control vector (left) or Flag-RK-BARF0 (right) were separated according
to their isoelectric points (first dimension) and molecular weights (second di-
mension). Protein expression was analyzed by immunoblotting by using an anti-
Flag MAb (upper and lower) followed by the anti-RK-BARF0 serum (lower).
Molecular size markers (expressed in kilodaltons) and the isoelectric point range
are given. Arrows and arrowheads indicate the positions of proteins specifically
detected by the anti-Flag MAb and by the anti-RK-BARF0 serum, respectively.
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than being membrane associated, the recombinant Flag-RK-
BARF0 protein was localized predominantly in the nucleus.
While these data demonstrate that the 30- to 35-kDa mem-
brane-associated proteins do not represent RK-BARF0, they
do not exclude the existence of the RK-BARF0 gene product
in EBV-positive cells. Thus far the best evidence that RK-
BARF0 and/or the BARF0 proteins are expressed in vivo
comes from the observations that RNA transcripts capable of
encoding these proteins exist in EBV-infected cells (4, 15, 18),
that antisera from NPC patients reacted with in vitro-trans-
lated BARF0 protein (8), and that the BARF0 ORF encodes
an HLA class I-restricted T-cell epitope which was recognized
by CTLs from EBV-seropositive, but not -seronegative, indi-
viduals (11). The latter study and a subsequent report (10)
indicated that the BARF0 antigen levels were low in EBV-
infected cells, as LCLs and BL cell lines were poorly recog-
nized by BARF0-specific CTLs due to differential splicing of
the BARF0 ORF. It is apparent that final confirmation of the
expression of the RK-BARF0 protein and of its 16- and 20-
kDa derivatives in EBV-infected cells will require the genera-
tion of better antiserum. Since the 39 region of the BARF0
ORF did not appear to undergo any additional splicing events,
it should encode an amino acid sequence which is present in
most BARF0-derived proteins, and thus the sequence could be
used as a source of synthetic peptides for future antibody
production.
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